← Eichor
Study identifier: NCT06640894 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.

Condition: Cerebral Palsy, Spastic  ·  Sponsor: Amsterdam UMC, location VUmc

PhaseNA
Planned participants66
Who can joinAll sexes, 4 Years to 12 Years
Healthy volunteersNo

About this study

Rationale: Children with cerebral palsy (CP) experience limitations in walking ability due to functional motor impairments caused by neurodevelopmental damage during fetal or early child development. Due to these motor impairments, children with CP struggle to keep up with typically developing peers when participating in physical and/or social activities. Consequently, the development of these children may be hampered. Recently, functional power training (FPT) emerged as a potentially successful supplementary treatment method to improve participation in children with CP. It is understood that FPT is more effective than progressive resistance training in improving walking ability and endurance, and thereby better supports participation in ambulatory children with CP. Nevertheless, high-level scientific evidence underpinning the efficacy of FPT on these parameters in ambulant children with CP is still lacking. The investigators hypothesize that FPT effectively helps accomplish patient-tailored participation and activity goals in ambulant children with CP. Objective: This study aims to investigate whether twelve weeks of FPT (MegaPower training) effectively accomplish patient-tailored participation and activity goals in ambulant children with CP, when compared to their usual care. Additionally, the goal is to investigate i) whether MegaPower training improves walking ability, aerobic endurance, and anaerobic capacity; ii) what factors best identify which ambulant children with …

This description comes directly from the study's public registry record.

Talk to the study team

Rijk Dersjant, drs.  ·  +31 20 4440761  ·  r.dersjant@amsterdamumc.nl

Marjolein M. Van der Krogt, dr.  ·  +31 20 4440789  ·  m.vanderkrogt@amsterdamumc.nl

Always discuss trial participation with your own doctor first.

Locations (10)

Treant ZorggroepEmmen, Drenthe, NetherlandsRecruiting
MeremAlmere Stad, Flevoland, NetherlandsRecruiting
Adelante zorggroepValkenburg, Limburg, NetherlandsRecruiting
RevantBreda, North Brabant, NetherlandsNot Yet Recruiting
ReadeAmsterdam, North Holland, NetherlandsRecruiting
HeliomareHeemskerk, North Holland, NetherlandsRecruiting
MeremHilversum, North Holland, NetherlandsRecruiting
RoessinghEnschede, Overijssel, NetherlandsRecruiting
Revalidatie FrieslandBeetsterzwaag, Provincie Friesland, NetherlandsRecruiting
RevantGoes, Zeeland, NetherlandsNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06640894